Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 23, 2012 16:42 ET | Source: Novavax, Inc.

Novavax Announces $27 Million Equity Offering

ROCKVILLE, Md., Oct. 23, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced that it has raised a total of $27 million through the sale of 12,285,321 shares of its common stock to RA...
October 17, 2012 16:01 ET | Source: Novavax, Inc.

Novavax Reports Positive Top-Line Results From Two Phase 1 Trials of Pandemic Influenza Vaccine

Vaccine candidates met safety and immunogenicity endpoints in both trials Trials' results support further development of vaccine in larger trials -- Adjuvanted candidates, at all doses of...
October 15, 2012 16:04 ET | Source: Novavax, Inc.

Novavax Initiates Phase 1 Clinical Trial of RSV Vaccine Candidate in Elderly Adults

ROCKVILLE, Md., Oct. 15, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced that enrollment has begun in a Phase 1 dose-ranging clinical trial of its respiratory syncytial virus...
October 08, 2012 13:34 ET | Source: Novavax, Inc.

Novavax Initiates Phase 2 Clinical Trial of RSV Vaccine Candidate

ROCKVILLE, Md., Oct. 8, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced that enrollment has begun in a Phase 2 dose-ranging clinical trial of its respiratory syncytial virus (RSV)...
September 27, 2012 08:00 ET | Source: Novavax, Inc.

Novavax Presents RSV Vaccine Data at the 8th Annual International Respiratory Virus Symposium

Data Reinforce Previous Clinical and Preclinical Studies Successfully Induced F-Protein Specific Neutralizing Antibody Response Phase 2 Studies to Begin in the Fourth Quarter of...
September 06, 2012 13:50 ET | Source: Novavax, Inc.

NOVAVAX to Present at the Rodman & Renshaw 14th Annual Healthcare Conference

ROCKVILLE, Md., Sept. 6, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) a clinical-stage vaccine company, announced today that Stanley C. Erck, President and Chief Executive Officer of Novavax,...
September 04, 2012 10:28 ET | Source: Novavax, Inc.

NOVAVAX to Present at the 2012 Stifel Nicolaus Healthcare Conference

ROCKVILLE, Md., Sept. 4, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) a clinical-stage vaccine company, announced today that Stanley C. Erck, President and Chief Executive Officer of Novavax,...
August 13, 2012 11:05 ET | Source: Novavax, Inc.

NOVAVAX to Present at the 2012 Wedbush Life Sciences Conference

ROCKVILLE, Md., Aug. 13, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage vaccine company, announced today that Stanley C. Erck, President and Chief Executive Officer of Novavax,...
August 03, 2012 08:00 ET | Source: Novavax, Inc.

NOVAVAX Reports Second Quarter 2012 Financial Results

ROCKVILLE, Md., Aug. 3, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced its financial results for the second quarter and six months ended June 30, 2012. Second Quarter 2012 and...
July 27, 2012 09:00 ET | Source: Novavax, Inc.

NOVAVAX to Report Second Quarter 2012 Financial Results on August 3, 2012

ROCKVILLE, Md., July 27, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced that it will report its 2012 second-quarter financial results on Friday, August 3, 2012, before the U.S....